A detailed history of Susquehanna International Group, LLP transactions in Annexon, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 339,278 shares of ANNX stock, worth $2.45 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
339,278
Previous 151,501 123.94%
Holding current value
$2.45 Million
Previous $1.09 Million 53.04%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$4.33 - $6.79 $813,074 - $1.28 Million
187,777 Added 123.94%
339,278 $1.66 Million
Q1 2024

May 07, 2024

BUY
$4.03 - $7.81 $514,050 - $996,212
127,556 Added 532.7%
151,501 $1.09 Million
Q4 2023

Feb 14, 2024

SELL
$1.63 - $4.63 $320,361 - $909,984
-196,541 Reduced 89.14%
23,945 $108,000
Q3 2023

Nov 14, 2023

BUY
$2.13 - $3.84 $54,076 - $97,489
25,388 Added 13.01%
220,486 $520,000
Q2 2023

Aug 11, 2023

SELL
$2.1 - $6.37 $61,742 - $187,284
-29,401 Reduced 13.1%
195,098 $686,000
Q1 2023

May 16, 2023

BUY
$3.74 - $7.46 $449,327 - $896,251
120,141 Added 115.12%
224,499 $864,000
Q4 2022

Feb 14, 2023

BUY
$4.56 - $6.61 $416,811 - $604,193
91,406 Added 705.73%
104,358 $539,000
Q3 2022

Nov 14, 2022

SELL
$3.75 - $6.63 $125,662 - $222,171
-33,510 Reduced 72.12%
12,952 $80,000
Q2 2022

Aug 15, 2022

BUY
$2.11 - $4.06 $32,287 - $62,126
15,302 Added 49.11%
46,462 $175,000
Q1 2022

May 16, 2022

SELL
$2.73 - $11.94 $39,066 - $170,861
-14,310 Reduced 31.47%
31,160 $85,000
Q4 2021

Feb 14, 2022

BUY
$11.49 - $22.0 $522,450 - $1 Million
45,470 New
45,470 $522,000
Q3 2021

Nov 15, 2021

SELL
$16.35 - $23.4 $230,109 - $329,331
-14,074 Closed
0 $0
Q2 2021

Aug 11, 2021

BUY
$17.81 - $27.48 $250,657 - $386,753
14,074 New
14,074 $317,000
Q4 2020

Feb 16, 2021

SELL
$20.81 - $30.55 $858,454 - $1.26 Million
-41,252 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$17.5 - $30.23 $721,910 - $1.25 Million
41,252 New
41,252 $1.25 Million

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $344M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.